Rajthanee Hospital (RJH TB): Q4 Revenue Growth to Decelerate Sequentially as Covid Tailwind Fades
Q4 revenue is expected to slow down q/q as new Covid-19 cases in Thailand is declining steadily. However, non-covid business is recovering. The...
321 Views
CHG: Expect 4Q21 Earnings to Soften QoQ
Yesterdays’ analyst meeting came out with a neutral tone. We expect 4Q21 margins to decline, in-response to rollover from exceptionally high 3Q21...
311 Views
CHG: Even Stronger in 3Q21E
We upgrade our recommendation to BUY rating, from HOLD, with 2022E target price of Bt4.36, derived from 38.6x PE, which is its 3-year trading average.
266 Views
CHG: Covid Windfall Boosted 2Q21 Performance
We maintain HOLD rating with 2022E target price of Bt4.36, +28% from Bt3.40 previously, derived from 38.6x PE, which is its 3-year trading average.
231 Views
CHG: Its Resiliency During Covid Seems to Price In
We maintain HOLD rating with 2022E target price of Bt3.40, derived from 38.6x PE, which is its 3-year trading average. We attended analyst...
422 Views